The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
Open accessAbstract
Aims/hypothesis: SGLT-2 inhibitors (SGLT-2i) have been studied as potential treatments against NAFLD, showing varying beneficial effects. The molecular mechanisms mediating these effects have not been fully clarified. Herein, we investigated the impact of empagliflozin on NAFLD, focusing particularly on ER stress, autophagy and apoptosis. Methods: Five-week old ApoE(-/-) mice were switched from normal to a high-fat diet (HFD). After five weeks, mice were randomly allocated into a control group (HFD + vehicle) and Empa group (HFD + empagliflozin 10 mg/kg/day) for five weeks. At the end of treatment, histomorphometric analysis was performed in liver, mRNA levels of Fasn, Screbp-1, Scd-1, Ppar-γ, Pck-1, Mcp-1, Tnf-α, Il-6, F4/80, Atf4, Elf2α, Chop, Grp78, Grp94, Χbp1, Ire1α, Atf6, mTor, Lc3b, Beclin-1, P62, Bcl-2 and Bax were measured by qRT-PCR, and protein levels of p-EIF2α, EIF2a, CHOP, LC3II, P62, BECLIN-1 and cleaved CASPASE-8 were assessed by immunoblotting. Results: Empagliflozin-treated mice exhibited reduced fasting glucose, total cholesterol and triglyceride serum levels, as well as decreased NAFLD activity score, decreased expression of lipogenic enzymes (Fasn, Screbp-1c and Pck-1) and inflammatory molecules (Mcp-1 and F4/80), compared to the Control group. Empagliflozin significantly decreased the expression of ER stress molecules Grp78, Ire1α, Xbp1, Elf2α, Atf4, Atf6, Chop, P62(Sqstm1) and Grp94; whilst activating autophagy via increased AMPK phosphorylation, decreased mTOR and increased LC3B expression. Finally, empagliflozin increased the Bcl2/Bax ratio and inhibited CASPASE-8 cleavage, reducing liver cell apoptosis. Immunoblotting analysis confirmed the qPCR results. Conclusion: These novel findings indicate that empagliflozin treatment for five weeks attenuates NAFLD progression in ApoE(-/-) mice by promoting autophagy, reducing ER stress and inhibiting hepatic apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · cited 2×
“NAFLD ranges from simple steatosis without inflammation to non-alcoholic steatohepatitis (NASH), which, in some cases, can lead to cirrhosis and even hepatocellular carcinoma [1,2].”
BackgroundEndoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
Autophagy Suppresses Tumorigenesis through Elimination of p62
Mathew, R., Karp, C. M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.-Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.048 · Cited by 1,719
Hu, H., Tian, M., Ding, C., & Yu, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03083 · Cited by 1,131
Cell death induced by endoplasmic reticulum stress
Iurlaro, R., & Muñoz‐Pinedo, C. (2016) · The FEBS Journal · doi:10.1111/febs.13598 · Cited by 1,062
Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
Lee, A.-H., Scapa, E. F., Cohen, D. E., & Glimcher, L. H. (2008) · Science · doi:10.1126/science.1158042 · Cited by 977
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, E., & Bailly-Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 944
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
González-Rodríguez, Á., Mayoral, R., Agra, N., Valdecantos, M. P., Pardo, V, Miquilena-Colina, M. E., Vargas-Castrillón, J., Lo Iacono, O., Corazzari, M., Fimia, G. M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.162 · Cited by 615
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C. D., & Targher, G. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154170 · Cited by 553
Crosstalk of autophagy and apoptosis: Involvement of the dual role of autophagy under ER stress
Song, S., Tan, J., Miao, Y., Li, M., & Zhang, Q. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25785 · Cited by 522
Xu, L., Nagata, N., Nagashimada, M., Zhuge, F., Ni, Y., Chen, G., Mayoux, E., Kaneko, S., & Ota, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.028 · Cited by 493
Protective role of autophagy in neonatal hypoxia–ischemia induced brain injury
Carloni, S., Buonocore, G., & Balduini, W. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.022 · Cited by 441
Song, S., Tan, J., Miao, Y., & Zhang, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26137 · Cited by 361
Kahl, S., Gancheva, S., Straßburger, K., Herder, C., Machann, J., Katsuyama, H., Kabisch, S., Henkel, E., Kopf, S., Lagerpusch, M., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0641 · Cited by 360 · cited 1×
“, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (γ-GT), triglycerides, hepatic insulin sensitivity indices), or by intrahepatic fat content on CT, MRI and proton-magnetic resonance spectroscopy imaging [6,11].”
BackgroundThe SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Kashani, F., Roohani, S., Welschof, P., Kopp, M., Gödtel-Armbrust, U., Xia, N., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.009 · Cited by 298
Han, J. H., Oh, T. J., Lee, G., Maeng, H. J., Lee, D. H., Kim, K. M., Choi, S. H., Jang, H. C., Lee, H. S., Park, K. S., et al. (2017) · Diabetologia · doi:10.1007/s00125-016-4158-2 · Cited by 281
Silencing of Lipid Metabolism Genes through IRE1α-Mediated mRNA Decay Lowers Plasma Lipids in Mice
So, J.-S., Hur, K. Y., Tarrio, M., Ruda, V., Frank-Kamenetsky, M., Fitzgerald, K., Koteliansky, V., Lichtman, A. H., Iwawaki, T., Glimcher, L. H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.004 · Cited by 280
Carloni, S., Girelli, S., Scopa, C., Buonocore, G., Longini, M., & Balduini, W. (2010) · Autophagy · doi:10.4161/auto.6.3.11261 · Cited by 267
Jojima, T., Tomotsune, T., Iijima, T., Akimoto, K., Suzuki, K., & Aso, Y. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0169-x · Cited by 202
Salazar, M. R., Carbajal, H. A., Espeche, W. G., Leiva Sisnieguez, C. E., Balbín, E., Dulbecco, C. A., Aizpurúa, M., Marillet, A. G., & Reaven, G. M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.016 · Cited by 196
Jo, H., Choe, S. S., Shin, K. C., Jang, H., Lee, J. H., Seong, J. K., Back, S. H., & Kim, J. B. (2013) · Hepatology · doi:10.1002/hep.26126 · Cited by 189
Lee, P. C., Ganguly, S., & Goh, S. ‐. (2018) · Obesity Reviews · doi:10.1111/obr.12755 · Cited by 189
Pharmacotherapy of type 2 diabetes: An update
Upadhyay, J., Polyzos, S. A., Perakakis, N., Thakkar, B., Paschou, S. A., Katsiki, N., Underwood, P., Park, K.-H., Seufert, J., Kang, E. S., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2017.08.010 · Cited by 187
Self-citationSchierwagen, R., Maybüchen, L., Zimmer, S., Hittatiya, K., Bäck, C., Klein, S., Uschner, F. E., Reul, W., Boor, P., Nickenig, G., et al. (2015) · Scientific Reports · doi:10.1038/srep12931 · Cited by 179
Adingupu, D. D., Göpel, S. O., Grönros, J., Behrendt, M., Sotak, M., Miliotis, T., Dahlqvist, U., Gan, L.-M., & Jönsson-Rylander, A.-C. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0820-6 · Cited by 172
Honda, Y., Imajo, K., Kato, T., Kessoku, T., Ogawa, Y., Tomeno, W., Kato, S., Mawatari, H., Fujita, K., Yoneda, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146337 · Cited by 170
Sattar, N., Fitchett, D., Hantel, S., George, J. T., & Zinman, B. (2018) · Diabetologia · doi:10.1007/s00125-018-4702-3 · Cited by 168
Han, Y., Hu, Z., Cui, A., Liu, Z., Ma, F., Xue, Y., Liu, Y., Zhang, F., Zhao, Z., Yu, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08585-4 · Cited by 164
Aragón-Herrera, A., Feijóo-Bandín, S., Otero Santiago, M., Barral, L., Campos-Toimil, M., Gil-Longo, J., Costa Pereira, T. M., García-Caballero, T., Rodríguez-Segade, S., Rodríguez, J., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113677 · Cited by 163
Xu, C., Wang, W., Zhong, J., Lei, F., Xu, N., Zhang, Y., & Xie, W. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.013 · Cited by 161
Nasiri-Ansari, Ν., Dimitriadis, G. K., Agrogiannis, G., Perrea, D., Kostakis, I. D., Kaltsas, G., Papavassiliou, A. G., Randeva, H. S., & Kassi, E. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0749-1 · Cited by 159
Self-citationMetabolic liver disease in diabetes – From mechanisms to clinical trials
Dewidar, B., Kahl, S., Pafili, K., & Roden, M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154299 · Cited by 158
Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
Hatting, M., Zhao, G., Schumacher, F., Sellge, G., Masaoudi, M. A., Gaβler, N., Boekschoten, M. V., Müller, M. M., Liedtke, C., Cubero, F. J., et al. (2013) · Hepatology · doi:10.1002/hep.26271 · Cited by 127
Qiang, S., Nakatsu, Y., Seno, Y., Fujishiro, M., Sakoda, H., Kushiyama, A., Mori, K., Matsunaga, Y., Yamamotoya, T., Kamata, H., et al. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0102-8 · Cited by 116
Ranjbar, G., Mikhailidis, D. P., & Sahebkar, A. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154001 · Cited by 110
Kim, J. H., Moon, J. S., Byun, S. J., Lee, J. H., Kang, D. R., Sung, K., Kim, J. Y., & Huh, J. H. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01025-4 · Cited by 110
Autophagy: a new target for nonalcoholic fatty liver disease therapy
Mao, Y., Yu, F., Wang, J., Guo, C., & Fan, X. (2016) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s98120 · Cited by 109
Mechanisms in endocrinology: Non-alcoholic fatty liver disease in common endocrine disorders
Hazlehurst, J., & Tomlinson, J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0296 · Cited by 105
Holczer, M., Hajdú, B., Lőrincz, T., Szarka, A., Bánhegyi, G., & Kapuy, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225543 · Cited by 105
Packer, M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1732 · Cited by 105
Lee, S., Kim, S.-H., Hwang, S., Cherrington, N. J., & Ryu, D. (2017) · Oncotarget · doi:10.18632/oncotarget.18812 · Cited by 100
Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death
Shibusawa, R., Yamada, E., Okada, S., Nakajima, Y., Bastie, C. C., Maeshima, A., Kaira, K., & Yamada, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46402-6 · Cited by 90
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
Nakano, S., Katsuno, K., Isaji, M., Nagasawa, T., Buehrer, B. M., Walker, S., Wilkison, W. O., & Cheatham, B. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.02.005 · Cited by 89
To die or not to die: death signaling in nonalcoholic fatty liver disease
Akazawa, Y., & Nakao, K. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1451-5 · Cited by 86
Petito‐da‐Silva, T. I., Souza‐Mello, V., & Barbosa‐da‐Silva, S. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110539 · Cited by 85
Autophagy, NAFLD and NAFLD-Related HCC
Wu, W. K. K., Zhang, L., & Chan, M. T. V. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_10 · Cited by 82
Simvastatin activates Keap1/Nrf2 signaling in rat liver
Habeos, I. G., Ziros, P. G., Chartoumpekis, D. V., Psyrogiannis, A. I., Kyriazopoulou, V. E., & Papavassiliou, A. G. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0393-4 · Cited by 81
Self-citationDougherty, J. A., Guirguis, E. H., & Thornby, K. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020935105 · Cited by 80
Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases
Guo, B.-C., & Li, Z.-H. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00242 · Cited by 75
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kim, K., & Lee, B. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0137 · Cited by 73
Zhou, Y., & Wu, W. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475942 · Cited by 70
Klionsky, D. J., Abdelmohsen, K., Abe, A., J., A. M., Abeliovich, H., A., A. A., Adachi, H., Adams, C. M., D., A. P., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1147886 · Cited by 65
Obara, K., Shirakami, Y., Maruta, A., Ideta, T., Miyazaki, T., Kochi, T., Sakai, H., Tanaka, T., Seishima, M., & Shimizu, M. (2017) · Oncotarget · doi:10.18632/oncotarget.16874 · Cited by 63
Dimitriadis, G. K., Ansari, N. N., Agrogiannis, G., Kostakis, I. D., Randeva, M. S., Nikiteas, N. I., Patel, V. C., Kaltsas, G., Papavassiliou, A. G., Randeva, H. S., et al. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110487 · Cited by 58
Self-citationChen, Z., Liu, Y., Li, Y., Liu, P., Zhang, Y., & Wang, X. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.03.003 · Cited by 58
Roles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis
Li, C. P., Li, J. H., He, S. Y., Li, P., & Zhong, X. L. (2014) · Genetics and Molecular Research · doi:10.4238/2014.may.23.10 · Cited by 54
Hosokawa, K., Takata, T., Sugihara, T., Matono, T., Koda, M., Kanda, T., Taniguchi, S., Ida, A., Mae, Y., Yamamoto, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010190 · Cited by 54
Chiang, H., Lee, J., Huang, H., Huang, H. Y., Liu, H., & Huang, C. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14859 · Cited by 50
Wang, L., Chen, J., Ning, C., Lei, D., & Ren, J. T. (2018) · Current Drug Targets · doi:10.2174/1389450118666180516122517 · Cited by 43
Zhou, Y., Zhong, L., Yu, S., Shen, W., Cai, C., & Yu, H. (2020) · Aging · doi:10.18632/aging.103082 · Cited by 42
Katsiki, N., Perakakis, N., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.07.009 · Cited by 38
Self-citationDavid-Silva, A., Esteves, J. V. D. C., Morais, M., Freitas, H. S., Zorn, T. M. T., Corrêa‐Giannella, M. L., & Machado, U. F. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s242282 · Cited by 37
Daems, C., Welsch, S., Boughaleb, H., Vanderroost, J., Robert, A., Sokal, E., & Lysy, P. (2019) · Journal of Diabetes Research · doi:10.1155/2019/2813489 · Cited by 36
Rodrigues, G., Moreira, A. J., Bona, S., Schemitt, E. G., Marroni, C. A., Naso, F. C. D., Dias, A. S., Pires, T. R., Picada, J. N., & Marroni, N. P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3201873 · Cited by 30
Could glucose be a proaging factor?
Kassi, E. N., & Papavassiliou, A. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00329.x · Cited by 26
Self-citationShibata, M., Shibata, E., Fujioka, S., & Harada‐Shiba, M. (2015) · International Journal of Laboratory Medicine & Research · doi:10.15344/2455-4006/2015/107 · Cited by 5
Beyond glycemic control: New guidance on cardio-renal protection
Anastasilakis, A. D., Sternthal, E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.02.004 · Cited by 5
Self-citation
Cited by
Guo, X., Yin, X., Liu, Z., & Wang, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415489 · Cited by 412
Endoplasmic reticulum stress in liver diseases
Ajoolabady, A., Kaplowitz, N., Lebeaupin, C., Kroemer, G., Kaufman, R. J., Malhi, H., & Ren, J. (2023) · Hepatology · doi:10.1002/hep.32562 · Cited by 405
Updated mechanisms of MASLD pathogenesis
Li, Y., Yang, P., Ye, J., Xu, Q., Wu, J., & Wang, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02108-x · Cited by 300
Lin, X.-F., Cui, X.-N., Yang, J., Jiang, Y.-F., Wei, T.-J., Xia, L., Liao, X.-Y., Li, F., Wang, D.-D., Li, J., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01389-3 · Cited by 69
Metadata
- Authors
- Nasiri-Ansari, N., Nikolopoulou, C., Papoutsi, K., Kyrou, I., Mantzoros, C. S., Kyriakopoulos, G., Chatzigeorgiou, A., Kalotychou, V., Randeva, M. S., Chatha, K., Kontzoglou, K., Kaltsas, G., Papavassiliou, A. G., Randeva, H. S., & Kassi, E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 818
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3118300923
- Cited by
- 297
- References
- 70
- FWCI
- 31.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.